The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Liver transplantation using fatty livers: Always feasible?
Open accessAbstract
Steatotic liver grafts represent the most common type of "extended criteria" organs that have been introduced during the last two decades due to the disparity between liver transplant candidates and the number available organs. A precise definition and reliable and reproducible method for steatosis quantification is currently lacking and the potential influence of the chemical composition of hepatic lipids has not been addressed. In our view, these shortcomings appear to contribute significantly to the inconsistent results of studies reporting on graft steatosis and the outcome of liver transplantation. In this review, various definitions, prevalence and methods of quantification of liver steatosis will be covered. Ischemia/reperfusion injury of the steatotic liver and its consequences on post-transplant outcome will be discussed. Selection criteria for organ allocation and a number of emerging protective strategies are suggested.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Donnelly, K. L., Smith, C. I., Schwarzenberg, S. J., Jessurun, J., Boldt, M. D., & Parks, E. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23621 · Cited by 3,604
RISK FACTORS FOR PRIMARY DYSFUNCTION AFTER LIVER TRANSPLANTATION—A MULTIVARIATE ANALYSIS
PLOEG, R. J., DʼALESSANDRO, A. M., KNECHTLE, S. J., STEGALL, M. D., PIRSCH, J. D., HOFFMANN, R. M., SASAKI, T., SOLLINGER, H. W., BELZER, F. O., & KALAYOGLU, M. (1993) · Transplantation · doi:10.1097/00007890-199304000-00024 · Cited by 1,026
The utility of marginal donors in liver transplantation
Busuttil, R. W., & Tanaka, K. (2003) · Liver Transplantation · doi:10.1053/jlts.2003.50105 · Cited by 662
Pessayre, D., & Fromenty, B. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.03.004 · Cited by 441 · cited 1×
“The second step is characterized by the excessive production of reactive oxygen species (ROS), generated by mitochondria and cytochrome P-450 system in fatty hepatocytes [11].”
Fatty Liver in Liver Transplantation and Surgery
Selzner, M., & Clavien, P.-A. (2001) · Seminars in Liver Disease · doi:10.1055/s-2001-12933 · Cited by 429
Self-citationAmarapurkar, D. N., Hashimoto, E., Lesmana, L. A., Sollano, J. D., Chen, P., Goh, K., & NAFLD, F. T. A. W. P. O. (2007) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2007.05042.x · Cited by 395
Sirolimus Is Associated with New-Onset Diabetes in Kidney Transplant Recipients
Johnston, O., Rose, C. L., Webster, A. C., & Gill, J. S. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007111202 · Cited by 359
PRIMARY NONFUNCTION OF HEPATIC ALLOGRAFTS WITH PREEXISTING FATTY INFILTRATION1
TODO, S., DEMETRIS, A. J., MAKOWKA, L., TEPERMAN, L., PODESTA, L., SHAVER, T., TZAKIS, A., & STARZL, T. E. (1989) · Transplantation · doi:10.1097/00007890-198905000-00034 · Cited by 353
The Biopsied Donor Liver: Incorporating Macrosteatosis Into High-Risk Donor Assessment
Spitzer, A. L., Lao, O. B., Dick, A. A. S., Bakthavatsalam, R., Halldorson, J. B., Yeh, M. M., Upton, M. P., Reyes, J. D., & Perkins, J. D. (2010) · Liver Transplantation · doi:10.1002/lt.22085 · Cited by 342
Fondevila, C., Hessheimer, A. J., Ruiz, A., Calatayud, D., Ferrer, J., Charco, R., Fuster, J., Navasa, M., Rimola, A., Taurá, P., et al. (2007) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2007.01846.x · Cited by 319
Chitturi, S., Farrell, G. C., Hashimoto, E., Saibara, T., Lau, G. K., Sollano, J. D., & NAFLD, T. A. W. P. O. (2007) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2007.05001.x · Cited by 312
Assessment of Hepatic Steatosis by Expert Pathologists: The End of a Gold Standard
El-Badry, A. M., Breitenstein, S., Jochum, W., Washington, K., Paradis, V., Rubbia-Brandt, L., Puhan, M. A., Slankamenac, K., Graf, R., & Clavien, P.-A. (2009) · Annals of Surgery · doi:10.1097/sla.0b013e3181bcd6dd · Cited by 307
Self-citationReport of the Paris Consensus Meeting on Expanded Criteria Donors in Liver Transplantation
Durand, F., Renz, J. F., Alkofer, B., Burra, P., Clavien, P.-A., Porte, R. J., Freeman, R. B., & Belghiti, J. (2008) · Liver Transplantation · doi:10.1002/lt.21668 · Cited by 304
Self-citationO'Brien, A. W. (1905) · The Elementary School Teacher · doi:10.1086/453500 · Cited by 303
USE OF FATTY DONOR LIVER IS ASSOCIATED WITH DIMINISHED EARLY PATIENT AND GRAFT SURVIVAL
Marsman, W. A., Wiesner, R. H., Rodriguez, L., Batts, K. P., Porayko, M. K., Hay, J. E., Gores, G. J., & Krom, R. A. F. (1996) · Transplantation · doi:10.1097/00007890-199611150-00011 · Cited by 302
USE OF LIVERS WITH MICROVESICULAR FAT SAFELY EXPANDS THE DONOR POOL
Fishbein, T. M., Fiel, M. I., Emre, S., Cubukcu, O., Guy, S. R., Schwartz, M. E., Miller, C. M., & Sheiner, P. A. (1997) · Transplantation · doi:10.1097/00007890-199707270-00012 · Cited by 272
Verran, D., Kusyk, T., Painter, D., Fisher, J., Koorey, D., Strasser, S., Stewart, G., & McCaughan, G. (2003) · Liver Transplantation · doi:10.1053/jlts.2003.50099 · Cited by 259
Cameron, A. M., Ghobrial, R. M., Yersiz, H., Farmer, D. G., Lipshutz, G. S., Gordon, S. A., Zimmerman, M., Hong, J., Collins, T. E., Gornbein, J., et al. (2006) · Annals of Surgery · doi:10.1097/01.sla.0000219669.84192.b3 · Cited by 257
Use of Severely Steatotic Grafts in Liver Transplantation: A Matched Case-Control Study
McCormack, L., Petrowsky, H., Jochum, W., Mullhaupt, B., Weber, M., & Clavien, P.-A. (2007) · Annals of Surgery · doi:10.1097/sla.0b013e31815c2a3f · Cited by 247
Self-citationNon-Alcoholic Fatty Liver Disease in Liver Transplant Recipients: Another Story of “Seed and Soil”
Dumortier, J., Giostra, E., Belbouab, S., Morard, I., Guillaud, O., Spahr, L., Boillot, O., Rubbia-Brandt, L., Scoazec, J.-Y., & Hadengue, A. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2009.717 · Cited by 217
Petrowsky, H., McCormack, L., Trujillo, M., Selzner, M., Jochum, W., & Clavien, P.-A. (2006) · Annals of Surgery · doi:10.1097/01.sla.0000246834.07130.5d · Cited by 213
Self-citationOmega 3 – Omega 6: What is right for the liver?
El-Badry, A. M., Graf, R., & Clavien, P.-A. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.08.005 · Cited by 201
Self-citationMiller, K. (2007) · Cited by 191
Malagó, M., Testa, G., Frilling, A., Nadalin, S., Valentin-Gamazo, C., Paul, A., Lang, H., Treichel, U., Cicinnati, V., Gerken, G., et al. (2003) · Annals of Surgery · doi:10.1097/01.sla.0000098619.71694.74 · Cited by 178
When is steatosis too much for transplantation?
Nocito, A., El-Badry, A. M., & Clavien, P.-A. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.07.017 · Cited by 164
Self-citationHepatic steatosis and its relationship to transplantation
Imber, C. J., St. Peter, S. D., Handa, A., & Friend, P. J. (2002) · Liver Transplantation · doi:10.1053/jlts.2002.32275 · Cited by 162
Posttransplant Metabolic Syndrome
Pagadala, M. R., Dasarathy, S., Eghtesad, B., & McCullough, A. J. (2009) · Liver Transplantation · doi:10.1002/lt.21952 · Cited by 155
In vivo demonstration of impaired microcirculation in steatotic human liver grafts
Seifalian, A. M., Chidambaram, V., Rolles, K., & Davidson, B. R. (1998) · Liver Transplantation and Surgery · doi:10.1002/lt.500040110 · Cited by 154
Zamboni, F., Franchello, A., David, E., Rocca, G., Ricchiuti, A., Lavezzo, B., Rizzetto, M., & Salizzoni, M. (2001) · Clinical Transplantation · doi:10.1034/j.1399-0012.2001.150109.x · Cited by 144
Assessing risk of the use of livers with macro and microsteatosis in a liver transplant program
Ureña, M. Á. G., Ruizdelgado, F. C., González, E. M., Segurola, C. L., Romero, C. J., Garcı́a, I. G., González-Pinto, I., & Sanz, R. (1998) · Transplantation Proceedings · doi:10.1016/s0041-1345(98)01033-1 · Cited by 134
Selzner, N., Selzner, M., Jochum, W., Amann-Vesti, B. R., Graf, R., & Clavien, P. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.07.032 · Cited by 128
Self-citationWhat is critical for liver surgery and partial liver transplantation: Size or quality?
Clavien, P., Oberkofler, C., Raptis, D., Lehmann, K., Rickenbacher, A., & El-Badry, A. (2010) · Hepatology · doi:10.1002/hep.23713 · Cited by 127
Self-citationEl‐Badry, A. M., Moritz, W., Contaldo, C., Tian, Y., Graf, R., & Clavien, P. (2007) · Hepatology · doi:10.1002/hep.21625 · Cited by 114
Self-citationMachine Perfusion for ‘Marginal’ Liver Grafts
Dutkowski, P., de Rougemont, O., & Clavien, P. (2008) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2008.02165.x · Cited by 111
Self-citationTheruvath, T. P., Zhong, Z., Pediaditakis, P., Ramshesh, V. K., Currin, R. T., Tikunov, A. P., Holmuhamedov, E., & Lemasters, J. J. (2007) · Hepatology · doi:10.1002/hep.21912 · Cited by 107
The Economic Impact of the Utilization of Liver Allografts with High Donor Risk Index
Axelrod, D. A., Schnitzler, M. A., Salvalaggio, P., Swindle, J. P., & Abecassis, M. (2007) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2006.01724.x · Cited by 101
Therapy of nonalcoholic fatty liver disease: current status.
Duvnjak, M., Tomašić, V., Gomerčić, M., Duvnjak, L. S., Baršić, N., & Lerotić, I. (2009) · PubMed · Cited by 90
Impact of donor liver microvesicular steatosis on the outcome of liver retransplantation
Yoong, K., Gunson, B. K., Neil, D., Mirza, D. F., Mayer, A. D., Buckels, J. A. C., & McMaster, P. (1999) · Transplantation Proceedings · doi:10.1016/s0041-1345(98)01550-4 · Cited by 82
Biological modulation of liver ischemia–reperfusion injury
de Rougemont, O., Dutkowski, P., & Clavien, P. (2010) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0b013e3283373ced · Cited by 80
Self-citationPatient selection in an era of donor liver shortage: current US policy
Wiesner, R. H. (2005) · Nature Clinical Practice Gastroenterology & Hepatology · doi:10.1038/ncpgasthep0070 · Cited by 71
Cho, J. Y., Suh, K., Kwon, C. H. D., Yi, N., & Lee, K. U. (2006) · Surgery · doi:10.1016/j.surg.2005.09.007 · Cited by 68
Risk of extended criteria donors in hepatitis C virus-positive recipients
Berenguer, M. (2008) · Liver Transplantation · doi:10.1002/lt.21617 · Cited by 50
Is a fatty liver dangerous for transplantation?
Canelo, R., Braun, F., Sattler, B., Klinge, B., Lorf, T., Ramadori, G. P., & Ringe, B. (1999) · Transplantation Proceedings · doi:10.1016/s0041-1345(98)01685-6 · Cited by 45
Marginal donors in liver transplantation: the role of donor age
Carlis, L. G. D., Colella, G., Sansalone, C. V., et al. (1999) · Transplantation Proceedings · doi:10.1016/s0041-1345(98)01678-9 · Cited by 40
Contribution of Marginal Donors to Liver Transplantation for Hepatitis C Virus Infection
Briceño, J., Ciria, R., Pleguezuelo, M., Naranjo, Á., Sánchez‐Hidalgo, J. M., Ruiz-Rabelo, J. F., López‐Cillero, P., Luque, A., de la Mata, M., & Rufián, S. (2007) · Transplantation Proceedings · doi:10.1016/j.transproceed.2007.07.069 · Cited by 31
Machicao, V. I., Krishna, M., Bonatti, H., et al. (2004) · Liver Transplantation · doi:10.1002/lt.20107 · Cited by 26
Ijaz, S., Winslet, M. C., & Seifalian, A. M. (2009) · Microvascular Research · doi:10.1016/j.mvr.2009.06.008 · Cited by 11
Cited by
Liver transplantation for hepatocellular carcinoma: outcomes and novel surgical approaches
Sapisochin, G., & Bruix, J. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2016.193 · Cited by 436
NAFLD and liver transplantation: Current burden and expected challenges
Pais, R., Barritt, A. S., Calmus, Y., Scatton, O., Runge, T., Lebray, P., Poynard, T., Ratziu, V., & Conti, F. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.07.033 · Cited by 430
Non-invasive diagnosis of non-alcoholic fatty liver disease. A critical appraisal
Machado, M. V., & Cortez-Pinto, H. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2012.11.021 · Cited by 412
Czigany, Z., Pratschke, J., Froněk, J., Guba, M., Schöning, W., Raptis, D. A., Andrassy, J., Kramer, M., Strnad, P., Tolba, R. H., et al. (2021) · Annals of Surgery · doi:10.1097/sla.0000000000005110 · Cited by 255
CREBZF as a Key Regulator of STAT3 Pathway in the Control of Liver Regeneration in Mice
Hu, Z., Han, Y., Liu, Y., Zhao, Z., Ma, F., Cui, A., Zhang, F., Liu, Z., Xue, Y., Bai, J., et al. (2020) · Hepatology · doi:10.1002/hep.30919 · Cited by 65
Metadata
- Authors
- McCormack, L., Dutkowski, P., El-Badry, A. M., & Clavien, P.-A.
- Venue
- Journal of Hepatology
- Publisher
- Elsevier BV
- Published
- 2011-05
- Volume
- 54
- Issue
- 5
- Pages
- 1055-1062
- ISSN
- 0168-8278 (ISSN-L)
- OpenAlex
- W1983803702
- Cited by
- 281
- References
- 47
- FWCI
- 12.42
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.